Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.


Letter to the editor: Bridenstine trying to protect long-term care

DATE: May 31, 2016

Most people are familiar with their local retail pharmacy — you get a prescription, take it to the pharmacy and go home with your medication.

Patients living in skilled nursing or other long-term care facilities, however, rely on long-term care pharmacies to provide clinical oversight and medication management services, as a majority of Medicare Part D beneficiaries residing in these settings juggle multiple prescriptions.

Long-term pharmacies are bound to the pricing terms set by pharmacy management services, third-party negotiators that have implemented unfair pricing practices that are driving up drug costs to patients and taxpayers.

Though these services claim to reduce prescription drug costs, they clearly do the opposite. For example, prices for the same prescription drug on the same day vary considerably for different payers, which raises questions about the relationship between price variation and the actual conditions of the market.

Ultimately, if management services are able to continue to negotiate drug prices unchecked, it will continue to drive up costs and jeopardize quality patient care.

Thankfully, Rep. Jim Bridenstine is stepping up to stop these veiled pricing practices by supporting House Resolution 244, the MAC Transparency Act. This legislation aims to increase transparency in service management practices and fairness in prescription drug pricing.

I commend him for co-sponsoring legislation that protects the interests of Medicare beneficiaries by ensuring access to fairly priced drugs.

Recent Posts

Stay in the Know

Get the latest news and updates on issues impacting the long-term pharmacy community.

See Latest Updates